DK1697005T3 - Kombination af flupirtin og tramadol - Google Patents
Kombination af flupirtin og tramadolInfo
- Publication number
- DK1697005T3 DK1697005T3 DK04803682.6T DK04803682T DK1697005T3 DK 1697005 T3 DK1697005 T3 DK 1697005T3 DK 04803682 T DK04803682 T DK 04803682T DK 1697005 T3 DK1697005 T3 DK 1697005T3
- Authority
- DK
- Denmark
- Prior art keywords
- flupirtine
- tramadol
- combination
- treament
- pain
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Artificial Filaments (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52976103P | 2003-12-17 | 2003-12-17 | |
| PCT/EP2004/014025 WO2005058420A1 (en) | 2003-12-17 | 2004-12-09 | Combination of flupirtine and tramadol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1697005T3 true DK1697005T3 (da) | 2011-12-12 |
Family
ID=34700037
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04803682.6T DK1697005T3 (da) | 2003-12-17 | 2004-12-09 | Kombination af flupirtin og tramadol |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7553858B2 (da) |
| EP (1) | EP1697005B1 (da) |
| JP (1) | JP4933265B2 (da) |
| CN (1) | CN1889996A (da) |
| AT (1) | ATE525112T1 (da) |
| AU (1) | AU2004298333B2 (da) |
| CA (1) | CA2546302C (da) |
| DK (1) | DK1697005T3 (da) |
| ES (1) | ES2373957T3 (da) |
| HR (1) | HRP20110914T1 (da) |
| MX (1) | MXPA06006999A (da) |
| NO (1) | NO335734B1 (da) |
| NZ (1) | NZ547256A (da) |
| PL (1) | PL1697005T3 (da) |
| PT (1) | PT1697005E (da) |
| RU (1) | RU2463042C2 (da) |
| SI (1) | SI1697005T1 (da) |
| WO (1) | WO2005058420A1 (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006024018A2 (en) * | 2004-08-24 | 2006-03-02 | Neuromolecular Pharmaceuticals, Inc. | Compositions for treating nociceptive pain |
| US7619007B2 (en) | 2004-11-23 | 2009-11-17 | Adamas Pharmaceuticals, Inc. | Method and composition for administering an NMDA receptor antagonist to a subject |
| KR101406456B1 (ko) | 2005-04-06 | 2014-06-20 | 아다마스 파마슈티칼스, 인코포레이티드 | Ｃｎｓ 장애의 치료를 위한 방법 및 조성물 |
| CA2688662A1 (en) * | 2007-04-27 | 2008-11-06 | Paratek Pharmaceuticals, Inc. | Methods for synthesizing and purifying aminoalkyl tetracycline compounds |
| US20120059024A1 (en) * | 2009-01-30 | 2012-03-08 | Relevare Aust. Pty Ltd | Drug abuse deterrent, methods and compositions |
| DE102010063612A1 (de) | 2010-12-20 | 2012-06-21 | Awd.Pharma Gmbh & Co. Kg | Neue Multikomponentenkristalle aus ([2-Amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamidsäureethylester und 2-[2-[(2,6-Dichlorphenyl)-amino]-phenyl]-essigsäure |
| DE102010063609A1 (de) | 2010-12-20 | 2012-06-21 | Awd.Pharma Gmbh & Co. Kg | Neue Multikomponentenkristalle aus ([2-Amino-6-(4-fluoro-benzylamino)-pyridin-3yl)-carbamidsäureethylester und einer Arylpropionsäure |
| WO2013127539A2 (de) * | 2012-03-02 | 2013-09-06 | Meda Pharma Gmbh & Co. Kg | Pharmazeutische formulierungen |
| US9693949B1 (en) | 2015-12-22 | 2017-07-04 | Revogenex Ireland Ltd | Intravenous administration of tramadol |
| US9980900B2 (en) | 2015-12-22 | 2018-05-29 | Revogenex Ireland Ltd | Intravenous administration of tramadol |
| RU2678976C1 (ru) * | 2018-03-21 | 2019-02-05 | федеральное государственное бюджетное образовательное учреждение высшего образования "Тверской государственный медицинский университет" Министерства здравоохранения Российской Федерации | Способ профилактики длительного болевого синдрома в отдаленном послеоперационном периоде у пациентов с дисплазией соединительной ткани |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0532627A (ja) * | 1991-07-29 | 1993-02-09 | Asta Medica Ag | 筋肉痙攣により帰因するか又は筋肉痙攣の結果である疾病及び症候群を治療するための医薬品及びその製法 |
| DE4236752A1 (de) * | 1992-10-30 | 1994-05-05 | Asta Medica Ag | Kombinationspräparat aus Flupirtin und Morphin zur Behandlung von Schmerzen und zur Vermeidung der Morphin-Abhängigkeit |
| DE19807535A1 (de) * | 1998-02-21 | 1999-08-26 | Asta Medica Ag | Pharmazeutische Kombinationen mit Tramadol |
| EP1242078A2 (de) * | 1999-08-03 | 2002-09-25 | AWD.pharma GmbH & Co.KG | Verwendung von flupirtin zur linderung von schmerzen bei degenerativen gelenkerkrankungen von hunden und katzen |
| RU2218189C1 (ru) * | 2002-05-28 | 2003-12-10 | Нижегородская государственная медицинская академия | Способ лечения мигрени в межприступном периоде заболевания |
-
2004
- 2004-12-03 US US11/002,762 patent/US7553858B2/en not_active Expired - Fee Related
- 2004-12-09 WO PCT/EP2004/014025 patent/WO2005058420A1/en active Application Filing
- 2004-12-09 RU RU2006125520/15A patent/RU2463042C2/ru not_active IP Right Cessation
- 2004-12-09 CA CA2546302A patent/CA2546302C/en not_active Expired - Fee Related
- 2004-12-09 NZ NZ547256A patent/NZ547256A/en unknown
- 2004-12-09 JP JP2006544286A patent/JP4933265B2/ja not_active Expired - Fee Related
- 2004-12-09 PT PT04803682T patent/PT1697005E/pt unknown
- 2004-12-09 SI SI200431786T patent/SI1697005T1/sl unknown
- 2004-12-09 EP EP04803682A patent/EP1697005B1/en active Active
- 2004-12-09 DK DK04803682.6T patent/DK1697005T3/da active
- 2004-12-09 CN CNA2004800366436A patent/CN1889996A/zh active Pending
- 2004-12-09 ES ES04803682T patent/ES2373957T3/es active Active
- 2004-12-09 PL PL04803682T patent/PL1697005T3/pl unknown
- 2004-12-09 AU AU2004298333A patent/AU2004298333B2/en not_active Ceased
- 2004-12-09 AT AT04803682T patent/ATE525112T1/de active
- 2004-12-09 MX MXPA06006999A patent/MXPA06006999A/es active IP Right Grant
-
2006
- 2006-07-17 NO NO20063308A patent/NO335734B1/no not_active IP Right Cessation
-
2011
- 2011-12-06 HR HR20110914T patent/HRP20110914T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP4933265B2 (ja) | 2012-05-16 |
| CN1889996A (zh) | 2007-01-03 |
| US20050137235A1 (en) | 2005-06-23 |
| ATE525112T1 (de) | 2011-10-15 |
| EP1697005A1 (en) | 2006-09-06 |
| HRP20110914T1 (hr) | 2011-12-31 |
| JP2007514672A (ja) | 2007-06-07 |
| RU2006125520A (ru) | 2008-01-27 |
| EP1697005B1 (en) | 2011-09-21 |
| NO335734B1 (no) | 2015-02-02 |
| NO20063308L (no) | 2006-09-12 |
| WO2005058420A1 (en) | 2005-06-30 |
| SI1697005T1 (sl) | 2012-01-31 |
| US7553858B2 (en) | 2009-06-30 |
| RU2463042C2 (ru) | 2012-10-10 |
| AU2004298333B2 (en) | 2009-12-17 |
| AU2004298333A1 (en) | 2005-06-30 |
| PL1697005T3 (pl) | 2012-02-29 |
| NZ547256A (en) | 2009-04-30 |
| ES2373957T3 (es) | 2012-02-10 |
| CA2546302C (en) | 2012-05-22 |
| MXPA06006999A (es) | 2006-12-14 |
| CA2546302A1 (en) | 2005-06-30 |
| PT1697005E (pt) | 2011-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20063308L (no) | Kombinasjon av flupirtin og tramadol | |
| DK1404331T3 (da) | Sustained release-formuleringer af oxymorphon | |
| IS6957A (is) | Tatrat sölt af 5,8,14,-tríasatetrasýkló[10.3.1.02,11.04,9]-hexadeka-2(11),3,5,7,9,-pentaen og lyfjafræðilegar samsetningar af þeim | |
| CY1105082T1 (el) | Χρηση της φλιβανσepινης στην αγωγη διαταραχων της σεξουαλικης επιθυμιας | |
| NO20035298D0 (no) | CDK-inhiberende pyrimider, deres fremstilling og deres anvendelse som legemidler | |
| DK1673104T3 (da) | Fremføring af terapeutiske forbindelser til hjernen og andre væv | |
| NO20040680L (no) | Nye dihydropterinonerfremgangsmate for fremstilling derav og deres anvendelse som legemiddel | |
| DK1513873T3 (da) | Terapeutiske epitoper og anvendelser deraf | |
| DK1803718T3 (da) | 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter | |
| NO20051983D0 (no) | 3-fenyl-substituert pyridoindolon, fremstilling derav og terapeutisk anvendelse derav. | |
| NO20044322L (no) | Benzoksanon-avledede forbindelser, deres fremstilling og anvendelse som medikament | |
| DK1513835T3 (da) | Piperazinylacylpiperidinderivater, fremstilling og terapeutisk anvendelse heraf | |
| NO20050689L (no) | Terapeutisk anvendelse | |
| IS7825A (is) | Meðferðarfræðileg meðhöndlun | |
| DK1417189T3 (da) | Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf | |
| DK1525193T3 (da) | Acylaminothiazolderivater, deres fremstilling og deres terapeutiske anvendelse | |
| NO20024838L (no) | Salter av bicykliske, N-acylerte imidazo-3-aminer og imidazo- 5-aminer | |
| NO20033123L (no) | Terapeutisk hinne dannende sammensetning og behandlingsplan derav | |
| DK1404304T3 (da) | Tablet omfattende cetirizin og pseudoephedrin | |
| DK1478366T3 (da) | Farmaceutiske kombinationer af meloxicam, codeinphosphat og paracetamol | |
| DE60326734D1 (de) | Ligations-behandlungsgerät | |
| DE60305053D1 (de) | Pyrimidinderivate als selektive cox-2-inhibitoren | |
| IS2331B (is) | 2-arýlimínó-2,3-díhýdróþíasólafleiður, aðferðir til að framleiða þær og meðferðarfræðileg notkun þeirra | |
| ATE343576T1 (de) | 7-azaindolderivate als cox2-inhibitoren | |
| DK1455770T3 (da) | Anvendelse af norepinephringenoptagelsesinhibitorer til behandling af tic lidelser |